within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonSteroids.M01AC05_Lornoxicam;
model Lornoxicam 
   extends Pharmacolibrary.Drugs.ATC.M.M01AC05;

  annotation(Documentation(
    info ="<html><body><p>Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class. It is used to treat acute and chronic pain, such as that caused by osteoarthritis and rheumatoid arthritis. Lornoxicam is approved in several countries for use as an analgesic and anti-inflammatory agent.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after a single oral dose, mixed sex population.</p><h4>References</h4><ol><li><p>Li, F, et al., &amp; Yang, X (2015). Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam. <i>Drug delivery</i> 22(4) 487–498. DOI:<a href=&quot;https://doi.org/10.3109/10717544.2014.885615&quot;>10.3109/10717544.2014.885615</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24524289/&quot;>https://pubmed.ncbi.nlm.nih.gov/24524289</a></p></li><li><p>Choi, CI, et al., &amp; Lee, SY (2011). Effects of the CYP2C9*1/*13 genotype on the pharmacokinetics of lornoxicam. <i>Basic &amp; clinical pharmacology &amp; toxicology</i> 109(6) 476–480. DOI:<a href=&quot;https://doi.org/10.1111/j.1742-7843.2011.00751.x&quot;>10.1111/j.1742-7843.2011.00751.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21726410/&quot;>https://pubmed.ncbi.nlm.nih.gov/21726410</a></p></li><li><p>Masche, UP, et al., &amp; Fattinger, KE (1999). Opposite effects of lornoxicam co-administration on phenprocoumon pharmacokinetics and pharmacodynamics. <i>European journal of clinical pharmacology</i> 54(11) 857–864. DOI:<a href=&quot;https://doi.org/10.1007/s002280050567&quot;>10.1007/s002280050567</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10027661/&quot;>https://pubmed.ncbi.nlm.nih.gov/10027661</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Lornoxicam;
